Page 47 - CA3.3
P. 47

118    วารสารโรคมะเร็ง                            ปีที� �� ฉบับที� � กรกฎาคม-กันยายน ����




                     16. Chua TC, Moran BJ, Sugarbaker PH, Levine EA,  21. Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A,
                         Glehen O, Gilly FN, et al. Early- and long-term out-  Efstathiou E, et al. Cytoreductive surgery and HIPEC
                         come data of patients with pseudomyxoma peritonei  in recurrent epithelial ovarian cancer: a prospective
                         from appendiceal origin treated by a strategy of  randomized phase III study. Ann Surg Oncol
                         cytoreductive surgery and hyperthermic intraperi-  2015;22:1570-5.
                         toneal chemotherapy. J Clin Oncol 2012;30:2449-56.  22. Votanopoulos KI, Shen P, Stewart JH 4th, Levine EA.
                     17. Jacquet P, Sugarbaker PH. Clinical research meth-  Current status and future directions in appendiceal
                         odologies in diagnosis and staging of patients with  cancer with peritoneal dissemination. Surg Oncol Clin
                         peritoneal carcinomatosis. Cancer Treat Res  N Am 2012;21:599-609.
                         1996;82:359-74.                        23. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL,
                     18. Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson  Beresnev TH, Mavroukakis SM, et al. Analysis of
                         GD, Goldberg RM, et al. Treatment of colorectal peri-  factors associated with outcome in patients with
                         toneal carcinomatosis with systemic chemotherapy:  malignant peritoneal mesothelioma undergoing
                         a pooled analysis of north central cancer treatment  surgical debulking and intraperitoneal chemotherapy.
                         group phase III trials N9741 and N9841. J Clin Oncol  J Clin Oncol 2003;21:4560-7.
                         2012;30:263-7.                         24. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S,
                     19. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J,  Katayama K, Bandou E, et al. Intraoperative
                         Baratti D, et al. The American Society of Peritoneal  chemohyperthermic peritoneal perfusion as an
                         Surface Malignancies (ASPSM) Multiinstitution Evalu-  adjuvant to gastric cancer: final results of a randomized
                         ation of the Peritoneal Surface Disease Severity  controlled study. Hepatogastroenterology 2001;
                         Score (PSDSS) in 1,013 patients with Colorectal  48:1776-82.
                         Cancer with Peritoneal Carcinomatosis. Ann Surg  25. Zhu ZG, Tang R, Yan M, Chen J, Yang QM, Li S, et al.
                         Oncol 2014;21:4195-201.                   Clinical effect of intraoperative peritoneal hyperther-
                     20. Armstrong DK, Bundy B, Wenzel L, Huang HQ,  mic chemotherapy for advanced gastric cancer.
                         Baergen R, Lele S, et al. Intraperitoneal cisplatin and  Zhonghua Wei Chang Wai Ke Za Zhi 2006;9:26-30.
                         paclitaxel  in  ovarian  cancer.  N  Engl  J  Med  26. Glockzin G, Piso P. Current status and future direc-
                         2006;354:34-43.                           tions in gastric cancer with peritoneal dissemination.
                                                                   Surg Oncol Clin N Am 2012;21:625-33.
   42   43   44   45   46   47   48   49